{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:17:32Z","timestamp":1789208252795,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-02556\\u201318"],"award-info":[{"award-number":["APQ-02556\\u201318"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-00931\\u201318"],"award-info":[{"award-number":["APQ-00931\\u201318"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-01661\\u201313"],"award-info":[{"award-number":["APQ-01661\\u201313"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-02638\\u201317"],"award-info":[{"award-number":["APQ-02638\\u201317"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["PPM-00710\\u201315"],"award-info":[{"award-number":["PPM-00710\\u201315"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ 03505"],"award-info":[{"award-number":["APQ 03505"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["435224\/2018\\u20132"],"award-info":[{"award-number":["435224\/2018\\u20132"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["486618\/2013\\u20137"],"award-info":[{"award-number":["486618\/2013\\u20137"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["310104\/2018\\u20131"],"award-info":[{"award-number":["310104\/2018\\u20131"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["301526\/2015\\u20130"],"award-info":[{"award-number":["301526\/2015\\u20130"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000077","name":"Division of Social and Economic Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003545","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009730","name":"Universidade Federal de Ouro Preto","doi-asserted-by":"publisher","award":["082017080"],"award-info":[{"award-number":["082017080"]}],"id":[{"id":"10.13039\/501100009730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.cellimm.2022.104592","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T13:09:28Z","timestamp":1662383368000},"page":"104592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A specific Leishmania infantum polyepitope vaccine triggers Th1-type immune response and protects against experimental visceral leishmaniasis"],"prefix":"10.1016","volume":"380","author":[{"given":"Thais","family":"Lopes Valentim Di Paschoale Ostolin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miri\u00e3","family":"Rodrigues Gusm\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Augusto Siqueira Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamille","family":"Mirelle de Oliveira Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Mendes Roatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Dian de Oliveira Aguiar-Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeronimo","family":"Concei\u00e7\u00e3o Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"de Melo Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Cristiane Fortes de Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Barbosa Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2022.104592_b0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.drudis.2008.12.007","article-title":"The use of genomics in microbial vaccine development","volume":"14","author":"Bambini","year":"2009","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.cellimm.2022.104592_b0010","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-016-1553-y","article-title":"Possibilities and challenges for developing a successful vaccine for leishmaniasis","volume":"9","author":"Srivastava","year":"2016","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.cellimm.2022.104592_b0015","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1590\/0037-8682-0120-2016","article-title":"Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis","volume":"49","author":"Duarte","year":"2016","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.cellimm.2022.104592_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003213","article-title":"A randomised, double-blind, controlled efficacy trial of the LiESP\/QA-21 vaccine in na\u00efve dogs exposed to two leishmania infantum transmission seasons","volume":"8","author":"Oliva","year":"2014","journal-title":"PLoS Negl.Trop. Dis."},{"key":"10.1016\/j.cellimm.2022.104592_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2020.105387","article-title":"Evaluation of canine leishmaniosis vaccine CaniLeish\u00ae under field conditions in native dog populations from an endemic Mediterranean area-A randomized controlled trial","volume":"205","author":"Velez","year":"2020","journal-title":"Acta Trop."},{"key":"10.1016\/j.cellimm.2022.104592_b0030","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.1016\/j.vaccine.2009.07.069","article-title":"The chimerical multi-component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection","volume":"27","author":"Carcel\u00e9n","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2022.104592_b0035","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.vaccine.2018.02.111","article-title":"A large-scale field randomized trial demonstrates safety and efficacy of the vaccine LetiFend\u00ae against canine leishmaniosis","volume":"36","author":"Fern\u00e1ndez Cotrina","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2022.104592_b0040","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.1016\/j.vaccine.2020.08.051","article-title":"Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union","volume":"38","author":"Calzetta","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2022.104592_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185438","article-title":"Field trial of efficacy of the Leish-tec\u00ae vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates","volume":"12","author":"Grimaldi","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2022.104592_b0050","unstructured":"Practical management of canine & feline leishmaniosis. Available at: https:\/\/www.leishvet.org\/wp-content\/uploads\/2018\/04\/LeishVet-Guidelines-4Ed.pdf [Accessed November 6, 2021]."},{"key":"10.1016\/j.cellimm.2022.104592_b0055","unstructured":"Manual de Vigil\u00e2ncia e Controle da Leishmaniose Visceral Bras\u00edlia-DF 2014 MINIST\u00c9RIO DA SA\u00daDE Secretaria de Vigil\u00e2ncia em Sa\u00fade Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica 1a edi\u00e7\u00e3o 5a reimpress\u00e3o. Available at: http:\/\/editora.saude.gov.br [Accessed November 6, 2021]."},{"key":"10.1016\/j.cellimm.2022.104592_b0060","doi-asserted-by":"crossref","unstructured":"A.A. Bahrami, Z. Payandeh, S. Khalili, A. Zakeri, M. Bandehpour, Immunoinformatics: In Silico Approaches and Computational Design of a Multi-epitope, Immunogenic Protein. International reviews of immunology (2019) 38:307\u2013322. doi:10.1080\/08830185.2019.1657426.","DOI":"10.1080\/08830185.2019.1657426"},{"key":"10.1016\/j.cellimm.2022.104592_b0065","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ymeth.2004.06.004","article-title":"From genome to vaccine\u2013new immunoinformatics tools for vaccine design","volume":"34","author":"de Groot","year":"2004","journal-title":"Methods (San Diego, Calif)"},{"key":"10.1016\/j.cellimm.2022.104592_b0070","article-title":"Vaccine informatics","volume":"2010","author":"He","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.cellimm.2022.104592_b0075","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1128\/IAI.71.5.2924-2926.2003","article-title":"Th1 cell development induced by cysteine proteinases A and B in localized cutaneous leishmaniasis due to Leishmania guyanensis","volume":"71","author":"Pascalis","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2022.104592_b0080","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12451","article-title":"Vaccine potential of HLA-A2 epitopes from Leishmania Cysteine Protease Type III (CPC)","volume":"39","author":"Dikhit","year":"2017","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2022.104592_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003091","article-title":"Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection","volume":"8","author":"Das","year":"2014","journal-title":"PLoS Negl.Trop. Dis."},{"key":"10.1016\/j.cellimm.2022.104592_b0090","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.vaccine.2003.11.014","article-title":"Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis","volume":"22","author":"Zadeh-Vakili","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2022.104592_b0095","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2011.04.011","article-title":"Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection","volume":"153","author":"Doroud","year":"2011","journal-title":"Journal of controlled release : official journal of the Controlled Release Society"},{"key":"10.1016\/j.cellimm.2022.104592_b0100","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1016\/j.vaccine.2008.08.065","article-title":"Cysteine proteinase type III is protective against Leishmania infantum infection in BALB\/c mice and highly antigenic in visceral leishmaniasis individuals","volume":"26","author":"Khoshgoo","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2022.104592_b0105","doi-asserted-by":"crossref","unstructured":"W.W. Zhang, G. Matlashewski, Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2. Proceedings of the National Academy of Sciences of the United States of America (1997) 94:8807\u20138811. doi:10.1073\/PNAS.94.16.8807.","DOI":"10.1073\/pnas.94.16.8807"},{"key":"10.1016\/j.cellimm.2022.104592_b0110","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.cellimm.2022.104592_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00465","article-title":"New Vaccine Formulations Containing a Modified Version of the Amastigote 2 Antigen and the Non-Virulent Trypanosoma cruzi CL-14 Strain Are Highly Antigenic and Protective against Leishmania infantum Challenge","volume":"9","author":"Almeida","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2022.104592_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092708","article-title":"In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis","volume":"9","author":"Chamakh-Ayari","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2022.104592_b0125","doi-asserted-by":"crossref","unstructured":"E. Petitdidier, J. Pagniez, G. Papierok, P. Vincendeau, J.L. Lemesre, R. Bras-Gon\u00e7alves, Recombinant Forms of Leishmania amazonensis Excreted\/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs. PLoS neglected tropical diseases (2016) 10: doi:10.1371\/JOURNAL.PNTD.0004614.","DOI":"10.1371\/journal.pntd.0004614"},{"key":"10.1016\/j.cellimm.2022.104592_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008093","article-title":"Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects","volume":"14","author":"Hamrouni","year":"2020","journal-title":"PLoS Negl.Trop. Dis."},{"key":"10.1016\/j.cellimm.2022.104592_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007880","article-title":"Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model","volume":"4","author":"Sachdeva","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2022.104592_b0140","doi-asserted-by":"crossref","DOI":"10.4172\/1948-5948.1000250","article-title":"Assessment of Protection Induced by DNA and Live Vaccine Encoding Leishmania MHC Class I Restricted Epitopes against L. major Challenge in Balb\/c Mice Model","volume":"7","author":"Zandieh","year":"2015","journal-title":"J Microb Biochem Technol"},{"key":"10.1016\/j.cellimm.2022.104592_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2014.11.003","article-title":"An overview of bioinformatics tools for epitope prediction: implications on vaccine development","volume":"53","author":"Soria-Guerra","year":"2015","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.cellimm.2022.104592_b0150","doi-asserted-by":"crossref","DOI":"10.2147\/ITT.S241064","article-title":"Immunoinformatics and Vaccine Development: An Overview","volume":"9","author":"Oli","year":"2020","journal-title":"Immunotargets Ther"},{"key":"10.1016\/j.cellimm.2022.104592_b0155","first-page":"37","article-title":"Visceral leishmaniasis: An overview of vaccine adjuvants and their applications","author":"Ratnapriya","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2022.104592_b0160","doi-asserted-by":"crossref","unstructured":"R.C.F. de Brito, J.M. de Oliveira Cardoso, L.E.S. Reis, J.F. Vieira, F.A.S. Mathias, B.M. Roatt, R.D. de O. Aguiar-Soares, J.C. Ruiz, D. de M. Resende, et al. Peptide Vaccines for Leishmaniasis. Front Immunol (2018) 9: doi:10.3389\/FIMMU.2018.01043.","DOI":"10.3389\/fimmu.2018.01043"},{"key":"10.1016\/j.cellimm.2022.104592_b0165","doi-asserted-by":"crossref","unstructured":"R.C.F. de Brito, J.C. Ruiz, J.M. de O. Cardoso, T.L.V.D.P. Ostolin, L.E.S. Reis, F.A.S. Mathias, R.D. de O. Aguiar-Soares, B.M. Roatt, R. Corr\u00eaa-Oliveira, D. de M. Resende, et al. Chimeric Vaccines Designed by Immunoinformatics-Activated Polyfunctional and Memory T Cells That Trigger Protection against Experimental Visceral Leishmaniasis. Vaccines (2020) 8: doi:10.3390\/VACCINES8020252.","DOI":"10.3390\/vaccines8020252"},{"key":"10.1016\/j.cellimm.2022.104592_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7040162","article-title":"Synthetic Peptides Elicit Strong Cellular Immunity in Visceral Leishmaniasis Natural Reservoir and Contribute to Long-Lasting Polyfunctional T-Cells in BALB\/c Mice","volume":"7","author":"de Brito","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.cellimm.2022.104592_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020371","article-title":"Immunoinformatics Features Linked to Leishmania Vaccine Development: Data Integration of Experimental and In Silico Studies","volume":"18","author":"Brito","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellimm.2022.104592_b0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.vetimm.2006.02.001","article-title":"Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi","volume":"112","author":"Reis","year":"2006","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.cellimm.2022.104592_b0185","article-title":"Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB\/c Mice","volume":"61","author":"Soares Reis","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cellimm.2022.104592_b0190","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2022.104592_b0195","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine Adjuvants: from 1920 to 2015 and Beyond","volume":"3","author":"di Pasquale","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.cellimm.2022.104592_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00100","article-title":"A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection","volume":"8","author":"Alves-Silva","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2022.104592_b0205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3024.2006.00840.x","article-title":"Immunology of canine leishmaniasis","volume":"28","author":"Barbi\u00e9ri","year":"2006","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2022.104592_b0210","article-title":"Functional aspects of T cell diversity in visceral leishmaniasis","volume":"117","author":"Jawed","year":"2019","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.cellimm.2022.104592_b0215","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12359","article-title":"A recombinant chimeric protein composed of human and mice-specific CD4 + and CD8 + T-cell epitopes protects against visceral leishmaniasis","volume":"39","author":"Martins","year":"2017","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2022.104592_b0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005311","article-title":"Identification of BALB\/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine","volume":"11","author":"Agallou","year":"2017","journal-title":"PLoS Negl.Trop. Dis."},{"key":"10.1016\/j.cellimm.2022.104592_b0225","doi-asserted-by":"crossref","DOI":"10.1038\/nm1210","article-title":"Targeting the innate immune response with improved vaccine adjuvants","volume":"11","author":"Pashine","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2022.104592_b0230","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/j.vaccine.2012.01.088","article-title":"Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice","volume":"30","author":"Dendouga","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2022.104592_b0235","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2022.104592_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00670","article-title":"Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy","volume":"10","author":"Dayakar","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2022.104592_b0245","doi-asserted-by":"crossref","unstructured":"J. Vitoriano-Souza, N. das D. Moreira, A. Teixeira-Carvalho, C.M. Carneiro, F.A.M. Siqueira, P.M.A. de Vieira, R.C. Giunchetti, S.A.L. de Moura, R.T. Fujiwara, M.N. Melo, et al. Cell recruitment and cytokines in skin mice sensitized with the vaccine adjuvants: saponin, incomplete Freund\u2019s adjuvant, and monophosphoryl lipid A. PloS one (2012) 7: doi:10.1371\/JOURNAL.PONE.0040745.","DOI":"10.1371\/journal.pone.0040745"},{"key":"10.1016\/j.cellimm.2022.104592_b0250","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","article-title":"Biology of interleukin-10","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cellimm.2022.104592_b0255","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.20061886","article-title":"CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis","volume":"204","author":"Anderson","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2022.104592_b0260","doi-asserted-by":"crossref","unstructured":"M.M. Kane, D.M. Mosser, The role of IL-10 in promoting disease progression in leishmaniasis. Journal of immunology (Baltimore, Md\u00a0: 1950) (2001) 166:1141\u20131147. doi:10.4049\/JIMMUNOL.166.2.1141.","DOI":"10.4049\/jimmunol.166.2.1141"},{"key":"10.1016\/j.cellimm.2022.104592_b0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2017","journal-title":"Expert review of vaccines"},{"key":"10.1016\/j.cellimm.2022.104592_b0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038859","article-title":"High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK\/MVA-LACK regimen in Leishmania major BALB\/c model of infection","volume":"7","author":"S\u00e1nchez-Sampedro","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2022.104592_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00018","article-title":"Liposomal Elongation Factor-1\u03b1 Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis","volume":"9","author":"Sabur","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2022.104592_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines8030350","article-title":"A Canine-Directed Chimeric Multi-Epitope Vaccine Induced Protective Immune Responses in BALB\/c Mice Infected with Leishmania infantum","volume":"8","author":"Agallou","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.cellimm.2022.104592_b0285","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature04790","article-title":"Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells","volume":"441","author":"Williams","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2022.104592_b0290","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrmicro1681","article-title":"The perfect mix: recent progress in adjuvant research","volume":"5","author":"Guy","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cellimm.2022.104592_b0295","doi-asserted-by":"crossref","DOI":"10.1186\/1297-9716-42-39","article-title":"Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB\/c mouse versus Syrian hamster model","volume":"42","author":"Nieto","year":"2011","journal-title":"Vet. Res."},{"key":"10.1016\/j.cellimm.2022.104592_b0300","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-016-1413-9","article-title":"Study of Leishmania pathogenesis in mice: experimental considerations","volume":"9","author":"Loeuillet","year":"2016","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.cellimm.2022.104592_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines8020289","article-title":"Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis","volume":"8","author":"Lage","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.cellimm.2022.104592_b0310","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trsl.2018.05.001","article-title":"Vaccination with a CD4 + and CD8 + T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis","volume":"200","author":"Dias","year":"2018","journal-title":"Translational research : the journal of laboratory and clinical medicine"},{"key":"10.1016\/j.cellimm.2022.104592_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104194","article-title":"A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis","volume":"356","author":"Oliveira-da-Silva","year":"2020","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2022.104592_b0320","first-page":"6186","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"Journal of immunology (Baltimore, Md\u00a0: 1950)"},{"key":"10.1016\/j.cellimm.2022.104592_b0325","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59 - an innately attractive adjuvant formulation","volume":"30","author":"O\u2019Hagan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2022.104592_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156363","article-title":"Immunoadjuvant Properties of the Rho Activating Factor CNF1 in Prophylactic and Curative Vaccination against Leishmania infantum","volume":"11","author":"Michel","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2022.104592_b0335","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1074\/jbc.M115.683011","article-title":"Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants","volume":"291","author":"Marty-Roix","year":"2016","journal-title":"The Journal of biological chemistry"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874922001174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874922001174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:46:17Z","timestamp":1778636777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874922001174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":67,"alternative-id":["S0008874922001174"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2022.104592","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A specific Leishmania infantum polyepitope vaccine triggers Th1-type immune response and protects against experimental visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2022.104592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104592"}}